Funder
Cempra, Inc.
Scandinavian Society for Antimicrobial Chemotherapy Foundation
Subject
Infectious Diseases,Microbiology
Reference21 articles.
1. Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages;Lemaire;Antimicrob. Agents Chemother.,2009
2. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis;Llano-Sotelo;Antimicrob. Agents Chemother.,2010
3. Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia;Oldach;Antimicrob. Agents Chemother.,2013
4. In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae;Piccinelli;Antimicrob. Agents Chemother.,2014
5. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria;Putnam;Diagn. Microbiol. Infect. Dis.,2010
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献